Be Biopharma
Drug DiscoveryWebsite
Developer of engineered B-cell medicines intended to transform treatment for patients with serious diseases. The company's drugs address major hurdles of cell and gene therapies and are durable, re-en...
Valuation
$0
Share Price
N/A
Total Raised
$274M
Last Round
Later Stage VC (Series C)
Oct 2024
Latest Funding Round
Later Stage VC (Series C)
Oct 1, 2024
$92M
raised
Investors
+11 other investors